ESKALE study, a French real-world study of esketamine nasal spray for patients with treatment-resistant depression

INTRODUCTION: Esketamine nasal spray has been developed to treat adults with treatment resistant depression. On Dec.2019, EMA granted a market access approval in this indication. OBJECTIVES: ESKALE is a descriptive study of treatment resistant depression patients treated with esketamine in France. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludovic, S., Codet, M.A., Rotharmel, M., De Maricourt, P., Boursicot, J., Gaudre Wattinne, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567231/
http://dx.doi.org/10.1192/j.eurpsy.2022.693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567231/
http://dx.doi.org/10.1192/j.eurpsy.2022.693

Ejemplares similares